111 (YI) EBIT Growth (3y) (2020 - 2025)
111 (YI) EBIT Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 29.94% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 26.79% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -3.82% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 1.32% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 20.42% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.54% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 85.70% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 6.25% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 85.70% |
| Sep 30, 2025 | 69.53% |
| Jun 30, 2025 | 26.02% |
| Mar 31, 2025 | 26.02% |
| Dec 31, 2024 | 60.58% |
| Sep 30, 2024 | 26.25% |
| Jun 30, 2024 | 26.32% |
| Mar 31, 2024 | 26.40% |
| Dec 31, 2023 | -9.46% |
| Sep 30, 2023 | 15.07% |
| Jun 30, 2023 | 24.22% |
| Mar 31, 2023 | 41.81% |
| Dec 31, 2022 | -38.40% |
| Sep 30, 2022 | -39.01% |
| Jun 30, 2022 | -41.12% |
| Mar 31, 2022 | -44.47% |
| Dec 31, 2021 | -41.81% |
| Sep 30, 2021 | -50.94% |
| Jun 30, 2021 | -24.67% |
| Mar 31, 2021 | -58.59% |